Connective Tissue Disease Flashcards

(36 cards)

1
Q

What is the pathogenesis of systemic lupus erythematosis (SLE)?

A

Defective apoptosis increases cell death and releases auto-antigens which form immune complexes. These deposit in small blood vessels, skin, kidneys and other places causing wide range of problems across the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How does systemic lupus erythematosis (SLE) present?

A

Wide ranging presentation as it affects multiple body systems.

Fever, fatigue, weight loss

Myalgia, arthalgia

Malar rash, alopecia, photosensitivity

Glomerulonephritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What may a FBC show in systemic lupus erythematosis (SLE)?

A

Low RBC, (anaemia)

Low WBC ( leukopenia)

Low platelets (thrombocytopenia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What markers can be used to assess SLE disease activity?

A

Complement (low in active disease as it is used up)

Anti-dsDNA (high in active disease)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What autoantibodies are associated with systemic lupus erythematosis (SLE)?

What are the specificities and sensitivities of these auto-antibodies?

A

Anti-nuclear antibody (ANA)
Anti-double stranded (anti-dsDNA)

ANA

  • high sensitivity (95% SLE patients positive)
  • non-specific (1/5 general people positive)

If ANA negative, they don’t have SLE. If its positive, doesn’t mean they definitely have SLE.

Anti-dsDNA

  • moderate specificity (60% SLE patents positive)
  • high specificity

If anti-dsDNA positive, they definitely have SLE. If its negative doesn’t mean they definitely don’t have SLE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What drug are most patients with systemic lupus erythematosis (SLE) on?

A

Hydroxychloroquine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is used in the treatment of mild, moderate and severe systemic lupus erythematosis (SLE)?

A

Mild

  • hydroxochloroquine
  • topical steroids (low dose <15mg/day)

Moderate

  • DMARDs (methotrexate, azathioprine)
  • oral steroids (moderate dose 0.5mg/day)

Severe

  • cyclophosphamide
  • IV steroids
  • biologics if resistance (ritixumab)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the most important investigation to do if systemic lupus erythematosis (SLE) is suspected/confirmed and what are you looking for?

A

Urinalysis to see if renal involvement

Proteinuria/heamaturia would suggest lupus nephritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What tests are used to monitor systemic lupus erythematosis (SLE)?

A

Measuring complement and anti-dsDNA (assesses disease activity)

Urinalysis (screen for lupus nephritis)

Blood pressure and cholesterol (assess cardiovascular risk factors, increased risk of CVD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is Sjogren’s syndrome?

A

Autoimmune condition causing disruption of lacrimal and salivary glands due to lymphocytic infiltration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How does Sjogren’s syndrome present?

A

Fatigue

Dry eyes, mouth, vagina

Parotid swelling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What clinical test can be useful in diagnosing Sjogren’s syndrome? What does it show?

A

Schirmer’s test
Assesses ocular dryness

Place filter paper in eyes and see how much water drains into paper (>5mm in 5 mins is positive)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What auto-antibodies are associated with Sjogren’s syndrome?

A

Anti-Ro

Anti-La

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the general treatment of Sjogren’s syndrome?

A

Symptomatic eye drops and salivary replacement drops

Hydroxychloroquine for fatigue/joint pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

In what circumstances would methotrexate be indicated in the treatment of Sjogren’s syndrome?

A

Organ involvement (e.g. interstitial lung disease)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What can Sjogren’s syndrome occur secondary to?

A
Rheumatoid arthritis (RA)
Systemic lupus erythematosis (SLE)
17
Q

What is systemic sclerosis?

A

Autoimmune disorder characterised by increased collagen production causing skin tightening, Raynaud’s phenomenon and some organ dysfunction

18
Q

What skin changes can be seen in systemic sclerosis?

A

Nose beaking
Tight skin around mouth
Sclerodactyly

19
Q

What is the progression of skin damage in systemic sclerosis?

A
  1. Oedematous
  2. Indurative (hardening)
  3. Atrophic
20
Q

What are the major and minor features of systemic sclerosis?

How does this help diagnosis?

A

Major - sclerosis of the skin of face, neck and arms

Minor - sclerodactyly, fingertip atrophy, bilateral lung fibrosis

Systemic sclerosis diagnosis confirmed with 1 major cutaneous feature and 2 minor cutaneous features

21
Q

What organs can be affected by systemic sclerosis?

A

Lungs (bilateral lung fibrosis)

Oesophagus (osophageal dysmotility causing acid reflux)

22
Q

What is the difference between limited and diffuse systemic sclerosis?

A

Limited systemic sclerosis

  • skin of face, arms and hands/feet involved
  • organ involvement occurs late

Diffuse systemic sclerosis

  • skin of trunk involved (rapid development)
  • organ involvement occurs early
23
Q

What autoantibodies are associated with systemic sclerosis?

Which is/are more common in limited and diffuse systemic sclerosis?

A

Anti-centromere (associated with limited)

Anti-Scl-70 (associated with diffuse)

24
Q

What is the treatment of systemic sclerosis?

A

No specific management

Management tailored towards specific issues

25
What treatment can be used for Raynaud's phenomenon?
Calcium channel blocker (amlodipine)
26
What treatment can be used for digital ulcers secondary to systemic sclerosis?
Iloprost infusion
27
What is anti-phospholipid syndrome (APS)?
Autoimmune disorder characterised by recurrent thrombosis
28
How does anti-phospholipid syndrome (APS) present?
Increased incidence of strokes, MI (possibly in young patient) Foetal loss Migraine Levido reticularis (lace-like purple discolouration of skin)
29
What is catastrophic anti-phospholipid syndrome (CAPS)
Rare but deadly (50% mortality) form of anti-phospholipid syndrome causing multi-organ infarction over days/weeks
30
What antibodies are associated with anti-phospholipid syndrome (APS)?
Anti-cardiolipin Anti-ß2-glycoprotein Lupus anticoagulant
31
What happens to the partial thromboplastin time (PTT) in anti-phospholipid syndrome (APS)?
Paradoxically prolonged
32
How is the treatment of anti-phospholipid syndrome (APS)?
If they have had thrombotic episode, lifelong warfarin If they have had recurrent pregnancy loss, life long LWMH (warfarin is teratogenic)
33
What is the management of a patient who has not had a thrombotic episode but is positive for all the antibodies associated with anti-phospholipid syndrome (APS)?
Nothing, they don't require anticoagulation
34
What is a positive result for anti-phospholipid syndrome (APS) autoantibodies?
Positive on 2 occasions 12 weeks apart
35
What is mixed connective tissue disease?
Defined condition characterised by features of other autoimmune connective tissue disorders
36
What autoantibodies are associated with mixed connective tissue disease?
Anti-RNP